Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03552055 · ClinicalTrials.gov registry record

Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation

A clinical trial of Gestational Age, sponsored by Gynuity Health Projects.

Completed
Registry status
245
Enrollment target
2
Study locations

NCT03552055 is a study of Gestational Age that has completed, run by Gynuity Health Projects. The registered enrollment target is 245 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03552055, a study of Gestational Age, has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
245 participants
Enrollment target
2
Study locations

Study Summary

Investigators will collect serum and urine specimens from pregnant patients along the full pregnancy continuum, assay each specimen for selected placental proteins, and examine the relationships between concentrations of the proteins and gestational age as determined by ultrasound.

Conditions Studied

Interventions

  • OTHER Non-interventional Study

Study Locations (2)

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • Planned Parenthood of Southeastern Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 245 participants
Start Date 2017-05-24
Est. Completion 2019-09-30

Sponsor

Gynuity Health Projects

29 total trials

What the Registry Record Tells You About NCT03552055

The ClinicalTrials.gov registry entry for NCT03552055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Age appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional Study is the first listed.

NCT03552055 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03552055 about?

NCT03552055 is a clinical study titled "Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation". Investigators will collect serum and urine specimens from pregnant patients along the full pregnancy continuum, assay each specimen for selected placental proteins, and examine the relationships between concentrations of the proteins and gestational age as determined by ultrasound.

What is the current status of trial NCT03552055?

This trial is currently completed. The enrollment target is 245 participants. The study started on 2017-05-24. Estimated completion is 2019-09-30.

What conditions does trial NCT03552055 study?

This clinical trial studies the following conditions: Gestational Age.

What interventions are being tested in trial NCT03552055?

The interventions under investigation include: Non-interventional Study (OTHER).

Who is sponsoring clinical trial NCT03552055?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03552055 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.